Why is Rheumatoid Arthritis Mortality Still High Despite the Advent of New Therapies? Comment on the Article by Widdifield et al.

González-Gay, Miguel A; Llorca, Javier; González-Juanatey, Carlos; Martín-Martínez, María A; Castañeda, Santos

González-Gay, Miguel A; Llorca, Javier; González-Juanatey, Carlos; Martín-Martínez, María A; Castañeda, Santos.

Afiliação

González-Gay MA; Hospital Universitario Marqués de Valdecilla, and Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain.
Llorca J; School of Medicine, University of Cantabria, IDIVAL, and CIBER Epidemiologíay Salud Pública (CIBERESP), Santander, Spain.
González-Juanatey C; Hospital Lucus Augusti Lugo, Spain.
Martín-Martínez MA; Spanish Society of Rheumatology, Madrid, Spain.
Castañeda S; Hospital Universitario de la Princesa, IIS-IPrincesa, Madrid, Spain.

Arthritis Care Res (Hoboken) ; 68(5): 726-7, 2016 05.

Article em En | MEDLINE | ID: mdl-26414613

Assuntos

Artrite Reumatoide; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google